These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1378690)

  • 21. Prostaglandin E1 in severe lower limb ischaemia: a double-blind controlled trial.
    Telles GS; Campbell WB; Wood RF; Collin J; Baird RN; Morris PJ
    Br J Surg; 1984 Jul; 71(7):506-8. PubMed ID: 6375799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia.
    Brass EP; Anthony R; Dormandy J; Hiatt WR; Jiao J; Nakanishi A; McNamara T; Nehler M;
    J Vasc Surg; 2006 Apr; 43(4):752-9. PubMed ID: 16616232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is transcutaneous oxygen and carbon dioxide monitoring indispensable in short- and long-term therapeutic management of non-reconstructable lower critical limb ischemia?
    Melillo E; Nuti M; Pedrinelli R; Buttitta F; Balbarini A
    Minerva Cardioangiol; 2006 Aug; 54(4):481-98. PubMed ID: 17016419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of severe foot ischaemia by defibrination with ancrod: a randomized blind study.
    Tønnesen KH; Sager P; Gormsen J
    Scand J Clin Lab Invest; 1978 Sep; 38(5):431-5. PubMed ID: 360366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization.
    Coppolino G; Buemi A; Bolignano D; Lacquaniti A; La Spada M; Stilo F; De Caridi G; Benedetto F; Loddo S; Buemi M; Spinelli F
    J Surg Res; 2009 Nov; 157(1):e129-35. PubMed ID: 19589539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost.
    Lessiani G; Vazzana N; Cuccurullo C; Di Michele D; Laurora G; Sgrò G; Di Ruscio P; Simeone E; Di Iorio P; Lattanzio S; Liani R; Ferrante E; Davì G
    Thromb Haemost; 2011 Feb; 105(2):321-8. PubMed ID: 21103664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia.
    Schellong S; Altmann E; von Bilderling P; Rudofsky G; Waldhausen P; Rogatti W
    Prostaglandins Leukot Essent Fatty Acids; 2004 Jun; 70(6):503-9. PubMed ID: 15120713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmentation of arterial blood velocity with electrostimulation in patients with critical limb ischemia unsuitable for revascularization.
    Yilmaz S; Mermi EU; Zobaci E; Aksoy E; Yastı Ç
    Vascular; 2017 Apr; 25(2):137-141. PubMed ID: 27154976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iloprost reduces peripheral resistance during femoro-distal reconstruction.
    Smith FC; Tsang GM; Watson HR; Shearman CP
    Eur J Vasc Surg; 1992 Mar; 6(2):194-8. PubMed ID: 1374040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why does placebo improve severe limb ischaemia?
    Vayssairat M; Baudot N; Sainte-Beuve C
    Lancet; 1988 Feb; 1(8581):356. PubMed ID: 2893161
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of stable prostacyclin analogue ZK 36 374 to treat severe lower limb ischaemia.
    Chiesa R; Vicari A; Mari G; Galimberti M; Di Carlo V; Pozza G
    Lancet; 1985 Jul; 2(8446):95-6. PubMed ID: 2409417
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of the prostacyclin analogue iloprost in the treatment of patients with critical limb ischaemia.
    Dormandy J
    Therapie; 1991; 46(4):319-22. PubMed ID: 1719654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcutaneous oxygen and carbon dioxide during treatment of critical limb ischemia with iloprost, a prostacyclin derivative.
    Melillo E; Iabichella L; Berchiolli R; Ferrari M; Catapano G; Dell'Omo G; Pedrinelli R
    Int J Microcirc Clin Exp; 1995; 15(2):60-4. PubMed ID: 8655253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness of prostanoids in patients with critical leg ischemia].
    Brodszky V; Farkas K; Járai Z; Landi A; Pécsvárady Z; Baji P; Balogh O; Gulácsi L; Péntek M
    Orv Hetil; 2011 Dec; 152(51):2047-55. PubMed ID: 22130202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous laser doppler flux distribution in ischemic ulcers and the effect of prostanoids: a crossover study comparing the acute action of prostaglandin E1 and iloprost vs saline.
    Gschwandtner ME; Koppensteiner R; Maca T; Minar E; Schneider B; Schnürer G; Ehringer H
    Microvasc Res; 1996 Jan; 51(1):29-38. PubMed ID: 8812752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
    Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
    J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcutaneous gases determination in diabetic critical limb ischemia.
    Melillo E; Ferrari M; Balbarini A; Pedrinelli R
    Diabetes Care; 2005 Aug; 28(8):2081-2. PubMed ID: 16043766
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma prothrombotic markers after a short- and middle term treatment with iloprost in arteriopathic patients with critical limb ischemia.
    Ferlito S; Di Salvo MM; Attanasio L; Finocchiaro PM; Condorelli PM; Mazzone D
    Panminerva Med; 1994 Jun; 36(2):76-9. PubMed ID: 7530356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, crossover comparison of iloprost with dextran in patients with peripheral arterial occlusive disease.
    Ylitalo P; Kaukinen S; Reinikainen P; Salenius JP; Vapaatalo H
    Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):197-204. PubMed ID: 1694831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment with iloprost of critical ischemia of the lower limbs associated with cardiac insufficiency. Study of the interaction with pharmacokinetics of digoxin].
    Cabane J; Bouslama K; Giral P; Benchouieb A; Picard O; Lebas J; Wattiaux MJ; Penin I; Souvignet G; Imbert JC
    Rev Med Interne; 1991; 12(6):465-70. PubMed ID: 1724324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.